Related Experiment Videos
[Hairy cell leukemia. Personal experience with 11 cases]
Bilten Za Hematologiju I Transfuziju
|January 1, 1983
Summary
Hairy cell leukemia (HCL) is a rare lymphoid malignancy. This study analyzed 11 HCL patients, noting splenomegaly and pancytopenia as common, with varied treatment responses and an average survival of 51 months.
Area of Science:
- Hematology
- Oncology
Context:
- Hairy cell leukemia (HCL) is a rare chronic lymphoid leukemia.
- Diagnosis is often delayed, with 78% of patients diagnosed at older ages.
- Splenomegaly is a universal clinical manifestation in HCL.
Purpose:
- To analyze the clinical and morphologic characteristics of hairy cell leukemia.
- To evaluate diagnostic methods and treatment outcomes in HCL patients.
Summary:
- The study reviewed 11 HCL cases, representing 2.5% of all leukemias.
- Key findings include splenomegaly (100%), pancytopenia, and characteristic hairy cells in peripheral blood (90%).
- Bone marrow biopsy and electron microscopy confirmed diagnosis in most cases. Complications included infections and hemorrhagic syndrome. Treatment with COP and CHOP protocols showed promising remission rates (62% and complete remission >12 months, respectively).
Impact:
- Highlights diagnostic challenges and common clinical features of hairy cell leukemia.
- Provides insights into treatment efficacy and survival outcomes for HCL patients.
- Contributes to understanding the management and prognosis of this rare leukemia.